Inhibitory effect of 5-fluorouracil on human cytochrome P(450) isoforms in human liver microsomes

Eur J Clin Pharmacol. 2003 Sep;59(5-6):407-9. doi: 10.1007/s00228-003-0641-z. Epub 2003 Aug 5.

Abstract

Objective: A number of case reports have been described regarding drug interactions with 5-fluorouracil (5-FU) and co-administered drugs. However, little is known regarding the inhibitory potential of 5-FU on the metabolism of co-administered drugs by cytochrome P(450) (CYP). The aim of the present study was to elucidate the inhibitory effect of 5-FU on CYP isoforms using human liver microsomes.

Methods: The inhibitory effect of 5-FU on CYP1A2, CYP2C9, CYP2C19, CYP2C8, CYP2E1, CYP2D6, and CYP3A4 activities was examined with specific probe drugs in human liver microsomes.

Results: 5-FU showed little or no inhibitory effect on CYP-catalyzed reactions in human liver microsomal preparations.

Conclusion: 5-FU has no inhibitory effect on CYP isoforms or drug metabolism causing drug interaction with 5-FU. The mechanism that causes drug interaction between co-administered drugs and 5-FU may not be related to direct CYP inhibition by 5-FU.

MeSH terms

  • Antineoplastic Agents / pharmacology*
  • Catalysis
  • Chromatography, High Pressure Liquid
  • Cytochrome P-450 Enzyme Inhibitors
  • Cytochrome P-450 Enzyme System / metabolism*
  • Drug Interactions
  • Fluorouracil / pharmacology*
  • Humans
  • In Vitro Techniques
  • Isoenzymes / antagonists & inhibitors
  • Isoenzymes / metabolism
  • Microsomes, Liver / drug effects*
  • Microsomes, Liver / enzymology
  • Pharmaceutical Preparations / metabolism
  • Pharmacokinetics

Substances

  • Antineoplastic Agents
  • Cytochrome P-450 Enzyme Inhibitors
  • Isoenzymes
  • Pharmaceutical Preparations
  • Cytochrome P-450 Enzyme System
  • Fluorouracil